超声引导下经皮微波消融治疗无人工腹水辅助的膈下心脏旁肝癌的可行性与安全性研究
回顾性纳入2020年1月至2022年12月在本院接受超声引导下微波消融的肝癌患者,按病灶距心包≤5 mm分为心脏旁组与非心脏旁组,心脏旁组消融中不使用人工腹水。两组技术成功率均为100%,局部肿瘤进展率与主要并发症率无显著差异,无心脏相关并发症。
要点
- 心脏旁肝癌(距心包≤5 mm)不使用人工腹水行超声引导微波消融技术成功率达100%。
- 心脏旁组局部肿瘤进展率2.63%、主要并发症率2.63%,均未见心脏相关并发症。
- 两组技术成功率、技术有效率、局部肿瘤进展率及主要并发症率差异均无统计学意义(P > .05)。
核心结论
- 超声引导下不使用人工腹水的微波消融治疗心脏旁肝癌是安全有效的。
研究设计与样本
- 回顾性研究,纳入2020年1月至2022年12月在本院接受超声引导下微波消融的79例患者共87个病灶,按病灶距心包是否≤5 mm分为心脏旁组与非心脏旁组。
诊断标准与关键数值
- 心脏旁组38例38个病灶,非心脏旁组41例49个病灶;两组技术成功率100% vs 100%、技术有效率100% vs 95.7%、局部肿瘤进展率2.63% vs 0%、主要并发症率2.63% vs 7.32%,差异均无统计学意义(P > .05)。
临床应用与阅片要点
- 对距心包≤5 mm的左叶及尾状叶肝癌,可参照本研究中不使用人工腹水的超声引导微波消融方案,术中及术后未发生心脏相关并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the efficacy and safety of ultrasound (US)-guided microwave ablation (MWA) without artificial ascites (AA) inpatients with sub-cardiac (SC) liver cancers.
METHODS: This retrospective study included patients with the left lobe and caudate lobe of the liver cancer who underwent US-guided MWA in our institute from January 2020 to December 2022. According to whether the target lesion was located ≤5 mm from the pericardium, patients were divided into the SC group and the non-sub-cardiac (NSC) group. In the SC group, AA was not employed during the ablation procedure. The results of technical success, technical efficiency, local tumour progression (LTP), and major complications were recorded.
RESULTS: A total of 79 patients with 87 lesions were enrolled. There were 38 patients with 38 lesions in the SC group and 41 patients with 49 lesions in the NSC group. The median follow-up of all patients was 15 (range, 3-44) months. There was no significant difference in technical success rates (100% vs 100%), technique efficiency rates (100% vs 95.7%), LTP rates (2.63% vs 0%,), and major complication rates (2.63% vs 7.32%) between the SC group and the NSC group (P > .05). No cardiac-related complications occurred.
CONCLUSIONS: US-guided MWA without AA for SC liver cancers was safe and effective.
ADVANCES IN KNOWLEDGE: The clinical prognosis of thermal ablation without AA in the treatment of SC liver cancers is still unclear. The finding of this study provided evidence supporting the efficacy and safety of US-guided MWA without AA for treating this tricky location.
引用
- Liu Q, Liang S, Liu H, et al. Feasibility and safety study of ultrasound-guided percutaneous microwave ablation for sub-cardiac liver cancers without artificial ascites assistance. Br J Radiol. 2024. PMID: 39177580. doi:10.1093/bjr/tqae169
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。